These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Cancer of the stomach--is a follow-up program of any importance for the patient?
    Author: Viste A, Rygh AB, Søreide O.
    Journal: Clin Oncol; 1984 Dec; 10(4):325-32. PubMed ID: 6210169.
    Abstract:
    The clinical course as well as the yield and therapeutic consequences of a strict follow-up program for 206 consecutively treated patients with cancer of the stomach were studied. Median survival was 6 months, varying from 36 months in patients with localized disease to 4 months in patients with distant metastases. Survival after a curative operation was 21 months (median); after a palliative operation survival was 3 months. The 5-year survival was 13%. During follow-up recurrence was detected in 19 out of 83 patients primarily resected for cure. Ten patients had a relaparotomy, and all had non-resectable disease. Recurrence occurred early, and usually within 9 months. Patients primarily operated on for palliation or found inoperable needed further palliative treatment 4 months post-operatively (median). In 27 patients the follow-up included gastroscopy, but recurrent disease was not diagnosed in any asymptomatic patients. We conclude that a regular follow-up program will be of minor importance in prolonging survival for patients with cancer of the stomach until effective cytotoxic regimens have been developed.
    [Abstract] [Full Text] [Related] [New Search]